Combined ATR and DNA-PK inhibition radiosensitizes tumor cells independently of their p53 status

H Hafsi, MT Dillon, HE Barker, JN Kyula, U Schick, JT Paget, HG Smith, M Pedersen, M McLaughlin, KJ Harrington